🕵️ Bio-Rad Laboratories, Inc. ($BIO)
SEC insider & ownership activity, last 12 months · CIK 12208 · every row links its SEC filing
Over the last 12 months insiders sold $350K with no open-market buying against it. James Barry sold $214K in discretionary trades (Nov). Norman D. Schwartz added 14.6% → 97.2%. No red-flag 8-Ks in the window.
🚨 2 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $350K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James Barry | 0 | – | 1 | $214K | Nov 6, 2025 |
| Eva Engelhardt | 0 | – | 1 | $136K | May 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Norman D. Schwartz | 97.2% | 13D | Sep 25, 2025 | filing ↗ | |
| Steven D. Schwartz | 80.8% | 13D | Sep 25, 2025 | filing ↗ | |
| Blue Raven Partners, L.P. | 80.1% | 13D | Sep 25, 2025 | filing ↗ | |
| Alice N. Schwartz | 12.3% | 13D | May 1, 2025 | filing ↗ | |
| First Eagle Investment Management, LLC | 11.4% | 13G | Aug 6, 2025 | filing ↗ | |
| Alice N. Schwartz Revocable Trust | 8.6% | 13D | Sep 25, 2025 | filing ↗ | |
| First Eagle Global Fund | 8.5% | 13G | Aug 6, 2025 | filing ↗ | |
| Blackrock, Inc. | 7.4% | 13G | Oct 17, 2025 | filing ↗ | |
| First Eagle Investment Management, LLC | 6.8% | 13G | May 5, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Alles Institute for Medical Research Corp | $219K | May 28, 2026 | filing ↗ |
| Eva Engelhardt | $136K | May 11, 2026 | filing ↗ |
| Michael W Crowley | $248K | Dec 2, 2025 | filing ↗ |
| Alles Institute for Medical Research Corp | $229K | Nov 18, 2025 | filing ↗ |
| James Barry | $215K | Nov 6, 2025 | filing ↗ |
| Michael W Crowley | $411K | Aug 5, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 19, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Earnings (2.02) | Oct 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 26, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |